PAPER O'Hare E, Scopes DI, Kim EM, Palmer P, Spanswick D, McMahon B, Amijee H, Nerou E, Treherne JM, Jeggo R
SEARCH RESULTS
331209 RESULTS
PAPER Polyakova M, Sonnabend N, Sander C, Mergl R, Schroeter ML, Schroeder J, Schönknecht P
Prevalence of minor depression in elderly persons with and without mild cognitive impairment: A systematic review.
J Affect Disord. 2013 Sep 25; PubMed: 24103852PAPER Davis KL
Cholinesterase Inhibitors in Alzheimer's Disease.
Neuropsychopharmacology. 1994 Dec;11(4):258. PubMed: 24105129PAPER Hardy J
Genetics of Alzheimer's disease: APP, APOE, and the chromosome 14 locus.
Neuropsychopharmacology. 1994 Dec;11(4):260. PubMed: 24105133PAPER Apter JT
New Drug Development--- Alzheimer' Disease.
Neuropsychopharmacology. 1994 Dec;11(4):264. PubMed: 24105144PAPER Doraiswamy M, Krishnan R, Ritchie J, Tupler L, McDonald W, Marcovina S, Knight D, Nemeroff C
Apolipoprotein E4 In Late Onset Depression.
Neuropsychopharmacology. 1994 Dec;11(4):268. PubMed: 24105160PAPER Siegel B, Shihabuddin L, Buchsbaum M
Gender Differences In Regional Brain Glucose Metabolism In Alzheimer'S Disease And Normal Aging.
Neuropsychopharmacology. 1994 Dec;11(4):285. PubMed: 24105226PAPER Cummings J, Zhong K
Biomarker-Driven Therapeutic Management of Alzheimer's Disease:Establishing the Foundations.
Clin Pharmacol Ther. 2013 Oct 8; PubMed: 24105258PAPER Dolma K, Iacobucci GJ, Hong Zheng K, Shandilya J, Toska E, White JA, Spina E, Gunawardena S
Presenilin influences glycogen synthase kinase-3 β (GSK-3β) for kinesin-1 and dynein function during axonal transport.
Hum Mol Genet. 2013 Oct 18; PubMed: 24105467PAPER Hong X, Liu J, Zhu G, Zhuang Y, Suo H, Wang P, Huang D, Xu J, Huang Y, Yu M, Bian M, Sheng Z, Fei J, Song H, Behnisch T, Huang F
Parkin overexpression ameliorates hippocampal long-term potentiation and β-amyloid load in an Alzheimer's disease mouse model.
Hum Mol Genet. 2013 Oct 20; PubMed: 24105468PAPER Epifanio I, Ventura-Campos N
Hippocampal shape analysis in Alzheimer's disease using functional data analysis.
Stat Med. 2013 Sep 16; PubMed: 24105806PAPER Santi S, Musi V, Descrovi E, Paeder V, Di Francesco J, Hvozdara L, van der Wal P, Lashuel HA, Pastore A, Neier R, Herzig HP
Real-time Amyloid Aggregation Monitoring with a Photonic Crystal-based Approach.
Chemphyschem. 2013 Oct 21;14(15):3476-82. PubMed: 24105966PAPER Nomura S, Umeda T, Tomiyama T, Mori H
The E693Δ (Osaka) mutation in amyloid precursor protein potentiates cholesterol-mediated intracellular amyloid β toxicity via its impaired cholesterol efflux.
J Neurosci Res. 2013 Dec;91(12):1541-50. Epub 2013 Sep 16 PubMed: 24105984PAPER Caselli RJ
Does an Alzheimer's disease susceptibility gene influence the cognitive effects of cancer therapy?
Pediatr Blood Cancer. 2013 Sep 17; PubMed: 24106134PAPER Poil SS, de Haan W, van der Flier WM, Mansvelder HD, Scheltens P, Linkenkaer-Hansen K
Integrative EEG biomarkers predict progression to Alzheimer's disease at the MCI stage.
Front Aging Neurosci. 2013;5:58. PubMed: 24106478Current Filters
No filters selected